Specifically, 68 Ga-PSMA PET/CT has been shown to have greater accuracy than bone and CT scanning for detecting metastatic disease, even changing cancer management in 27% of patients submitted to PSMA PET/CT that were enrolled in a prior trial [69]. The gene discussed is FOLH1; the disease is metastatic neoplasm.